key: cord-0986672-u25xc0ru
authors: Sloan, Melanie; Gordon, Caroline; Harwood, Rupert; Lever, Elliott; Wincup, Chris; Bosley, Michael; Brimicombe, James; Pilling, Mark; Sutton, Stephen; Holloway, Lynn; D’Cruz, David
title: The impact of the COVID-19 pandemic on the medical care and healthcare-behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal study
date: 2020-12-14
journal: Rheumatol Adv Pract
DOI: 10.1093/rap/rkaa072
sha: 35689b0794973164da520de32648042d7a787705
doc_id: 986672
cord_uid: u25xc0ru

OBJECTIVE: To explore the self-reported impact of the COVID-19 pandemic on changes to care and behaviour in UK patients with systemic autoimmune rheumatic diseases, to help ensure that patient experiences are considered in future pandemic planning. METHODS: This was a longitudinal mixed methods study, with a cohort completing baseline surveys in March 2020 and follow-up surveys in June 2020 (N = 111), combined with thematic analysis of the LUPUS UK forum and participant interviews (N = 28). RESULTS: Cancellations of routine care and difficulties accessing medical support contributed to some participants deteriorating physically, including reports of hospitalisations. The majority of participants reported that fear of COVID-19 and disruptions to their medical care had also adversely impacted their mental health. Feeling medically supported during the pandemic correlated with multiple measures of mental health and perceptions of care, including the Warwick-Edinburgh Mental Wellbeing Score (r = 0.44, p = 0.01). Five themes were identified: 1. Detrimental reduction in care; 2. Disparities in contact and communication, (medical security vs abandonment sub-theme); 3. Perceived and actual endangerment; 4. The ‘perfect storm’ of reduced clinician ability to help, and increased patient reticence to seek help; and 5. Identifying the patients most vulnerable to reduced medical care. CONCLUSION: The diversion of resources away from chronic disease care was perceived by many participants to have caused adverse outcomes. Fear about increased vulnerability to COVID-19 was high, contributing to healthcare-avoidant behaviours. This study also highlights the influence of clinician accessibility and patients feeling medically supported on multiple measures of physical and mental health.

The National Health Service (NHS) was already in a weakened state 1 , and the UK unprepared for a pandemic 2 , when the first UK COVID-19 case was recorded in January 2020 3 . Less than two months later, hospitals were instructed to postpone non-urgent care 4 ; and visits to GP practices 5 and A&E also declined 4 . These changes disrupted the provision of care for patients with chronic illnesses 6 , and there are indications that this could have disproportionately impacted those with systemic autoimmune rheumatic diseases (SARDs). This was due in part to rheumatologists having been largely redeployed to the COVID-19 frontline 7 , where they were uniquely qualified to help manage the potentially fatal hyperinflammatory complications of COVID-19 8 , with other rheumatology staff also redeployed 9 .

The consequent reduction in usual rheumatology care was particularly concerning in that SARD patients often have complex multi-system disease with potentially life-threatening manifestations 10 , which are generally poorly understood by non-specialist clinicians 11, 12 . It is of paramount importance to ensure that these SARD manifestations and "undetected serious adverse effects of ongoing treatments" 13 , particularly immunosuppressants 10 , do not lead to future complications. In addition, medical insecurity and distrust among SARD patients who experienced traumatic diagnostic journeys and previous negative medical interactions 14 could have left them psychologically vulnerable to COVID-19 related reductions in quality and continuity of care. Further distress may have arisen from uncertainty about whether immunosuppressive medication increased or reduced the risk of severe COVID-19 15 , along with concerns about the availability of hydroxychloroquine 16, 17 ,and from inadequate information about their own individual COVID-19 related risk, with a recent paper suggesting that at least one third of SLE patients should have been advised to shield 18 .

The principal aim of this study was to more fully understand the impact of these COVID-19 related healthcare changes, so that the health services are better able to deliver effective care for SARD patients during the continuing pandemic 19 and to plan for future UK health crises.

In so planning, it is essential to ensure that the experiences and views of patients are listened to and acted on, particularly with regards to understanding the effects of feeling medically supported (or not) during times of personal and national health crises.

This was a sequential multi-phase mixed-methods design, with the qualitative components being both exploratory and explanatory 20 . Ethical approval was obtained through the Cambridge Psychology Research Committee for each part of the research. Participants were recruited online through the LUPUS UK forum (>25,000 members) and Lupus support UK Facebook group (>7000 members) for a longitudinal pre-registered (ISRCTN-14966097) randomised controlled study investigating the feasibility and acceptability of peer-support by small email groups. Fully informed consent was taken online prior to questionnaire completion and recorded verbally prior to interviews. Inclusion criteria were: a diagnosis of lupus or other SARD (as detailed on their clinic letters), 18 years or above, and resident in the UK. The sample was based on opportunistic considerations.

Although the peer-support trial recruitment was coincidental to the pandemic, it provided a unique opportunity to compare these patients' views at key stages of the pandemic. The surveys incorporated validated tools for assessing patient wellbeing, mental health (MH) and disease acceptance, including the Warwick-Edinburgh Mental Wellbeing Scale (WEMWS) 21 and questions compiled by the study team and patients to capture perceived changes in care, medical support and impact on MH due to the pandemic. These were both positively and negatively framed to reduce bias. For example, 'My doctors have helped me with my lupus/CTD symptoms' and 'My medical appointments for my lupus/CTD have been cancelled/postponed' (Questions in this section were preceded with 'During the coronavirus pandemic' and response options were on a 5 point scale of: much less, less, no change, more, much more).

The study research stages and related key pandemic developments were as follows - 4. In-depth patient interviews (July 2020, N=28). Shielding for at risk groups ended (August 2020).

Interviewees were purposively sampled from follow-up survey responses to include a range of socio-demographic characteristics and medical experiences. Interview guides (Supplementary Data S1, available at Rheumatology Advances in Practice online) contained standardised and personalised questions designed from each survey response to further explore patients' views and experiences of medical care during the pandemic. Interviews were conducted by MS, mainly via the telephone, audio-recorded and transcribed verbatim, and lasted approximately 60 minutes. Interviewing continued until thematic/theoretical saturation was reached , with this being taken to the point at which the themes together addressed all the main research questions and additional interviews did not provide significant new relevant insights or contradict the conclusions drawn from earlier interviews.

The integration of qualitative and quantitative data occurred at all stages. Following 'immersion' in the data, it was analysed thematically 22 ; with MS using Nvivo12 to code it and RH double-coding 25% of transcripts to test and enhance reliability. Potential threats to validity were addressed by "member checking" 23 , triangulation of quantitative and qualitative data and examination of cases that deviated from the norm 24 . Common themes and concepts emerging from the data were then discussed and agreed by the wider team and multiple patients. Quantitative data was analysed principally using Pearson's correlation coefficient.

More detailed methodology and the COREQ checklist 25 for qualitative research are included in Supplementary Data S2, available at Rheumatology Advances in Practice online.

Response rate for the surveys was 80% (111/139 completing follow-up). The majority of respondents were female (in keeping with lupus predominantly affecting women) and included a wide range of sociodemographic and disease characteristics as shown in Table 1 .

Approximately 50% of survey participants reported being allocated to the shielding group.

Themes arising from the qualitative data were:

1. Detrimental reduction in care.

Disparities in contact and communication, incorporating a sub-theme of medical security vs abandonment.

4. The 'perfect storm' of reduced clinician ability to help and increased patient reticence to seek help.

Identifying the patients most vulnerable to reduced medical care.

Where percentages or any quantitative measures are given and/or respondents referred to, this is data from the survey, as opposed to interviewee data.

Survey and interview results indicated significant detrimental changes in medical care for the majority of these patients as shown in Figure 1 . Over 70% of respondents reported that their appointments, tests and treatments had been cancelled more/much more frequently since the pandemic began, and great concern was expressed about the lack of clinician availability when seeking support. Between 35 and 45% of respondents felt that care from GPs, rheumatologists and other specialists had been worse/much worse, and less than 30% reported feeling medically supported for their SARD during the pandemic.

As Figure 2 shows, patients reporting having felt medically supported was associated with overall reported wellbeing (r=0.44, p=0.01), measured by the validated WEMWS tool at baseline and follow-up, and strongly correlated (r=0.776, p=0.01) with helpfulness of doctors in answering questions about COVID-19 and risk levels. It was also significantly, albeit weakly, correlated with multiple improvements to physical health, self-efficacy, fatigue and anxiety. However, there was no correlation with changes to medication adherence or in raising MH concerns with physicians. Although participants discussed many negative impacts on their MH from COVID-19, the government's response to the pandemic and the reduction in medical care, no significant difference in overall wellbeing was measured on the WEMWS between baseline and follow-up.

There was considerable variation in participant reports of the quality of contact and care.

Explicit reassurance of physician accessibility and/or regular physician check-ins contributed to feeling 'cared about' and medically secure: At the other end of the spectrum, there was a widespread sense of abandonment, especially among those whose routine care was abruptly stopped and who could not access assistance in an emergency. Multiple patients, both in the study and on the forum, detailed repeated unsuccessful attempts to contact their rheumatology department:

The system abandoned its existing patients to make room for new ones due to There are no longer people out there whom we can speak to and ask help. Which doctor is there to help me? I left three messages…emails…phonecalls…did not hear anything back…it is very easy to fall into depression (Forum member, 40s) Table 2 sets-out suggestions to improve care and communication, along with illustrative quotes from patients. These suggestions are derived from an analysis of the relative success of the reported care and communication strategies, and from direct suggestions from participants as to what they felt would help in the future.

The experiences detailed in the interviews and summarised in Table 2 Interviews with other participants revealed discomfort and guilt from the difficulties rationalising the cognitive dissonance created by a feeling of personal medical abandonment, while also having concern for patients with COVID-19 and empathy for the pressures faced The repeated government warnings concerning the potential for the NHS to be overwhelmed increased both healthcare avoidance and fears:

'You're going to have to look after yourself and keep as well as possible and avoid A&E or need healthcare because it's not necessarily going to be available'…definitely increased my anxiety (Ppt 108, 30s) While a majority of participants felt that their chronic disease care had been adversely impacted due to prioritization of patients with COVID-19 (only ~20% agreed that patients with chronic diseases had been treated as well as COVID-19 patients), some also feared that their care, and potentially their lives, would also be less valued if they contracted COVID-19:

Are we considered a class of patients that can be sacrificed for the good of healthy others?...Feel quite scared that I will be seen as less worthy of saving than someone else due to my autoimmune illnesses. (Ppt 55, 40s) Some participants discussed how their initial fears were sometimes unfounded. A high proportion (~70%) of those who managed to access care reported strongly agreeing/agreeing that they had been helped with their SARD symptoms. Those who had been reticent to seek help due to COVID-19 infection risk in healthcare-settings sometimes also reported that the high level of precautions created a greater feeling of safety than anticipated.

The lower numbers of the general population attending hospital also resulted in many more positive experiences due to a less chaotic environment than normal, with likely COVID-19 patients often kept separate. However, with many rheumatologists redeployed, GPs and Emergency Medicine staff (while generally reported to be accessible and well-meaning) were strongly felt to lack sufficient knowledge of complex autoimmunity to safely manage these patients without specialist support:

[A&E] were good in that they were quick, but I wouldn't say they were experts in lupus, or the medication…that was quite scary (Ppt 108, 30s) Although many patients discussed feeling extremely endangered by COVID-19, few reported having COVID-19 symptoms (12%), and no survey respondents tested positive or were hospitalised for COVID-19 (although the avoidant behaviour will have reduced transmission likelihood). However, there were many reports of adverse impacts on physical and mental health from the reduction in care, including participants reporting attending Emergency Departments or being admitted due to untreated and/or uncontrolled disease activity or infections. Several participants felt this might have been avoidable and had tried unsuccessfully to contact rheumatology departments prior to deteriorating to the point of requiring admission. Others considered that the stress and lack of support had directly caused a flare.

The impact of COVID-19, combined with the changes to care, were exacerbated by decreased physician ability to help and increased patient reticence to seek help, creating the 'perfect storm' for adverse outcomes as depicted in Figure 3 . In addition to the high 

The patient groups identified (in Table 3 ) as potentially most vulnerable to a reduction in care included: those with severe active disease (particularly renal or pulmonary), the newly diagnosed, those who had started new treatments with regular monitoring required just prior to the pandemic, and those with uncertain diagnoses:

Those with a longer disease duration may be less vulnerable to temporary reductions in care and generally expressed more confidence in self-management during interviews. There were weak positive correlations between disease duration and feeling they could control their disease (r=0.26, p=0.01) and with feeling they had adapted to life with their disease (r=0.33, p=0.01): learn to be at peace with what you have (Ppt 104, 70s). However, even the most experienced patients at times require prompt professional medical support to avoid permanent damage, yet reports suggest this was not always forthcoming during the pandemic.

There were no statistically significant differences between demographic groups, including in terms of fears of catching COVID-19 and perceptions of medical support. However, some patients with co-morbidities, greater age and/or belonging to a Black, Asian or Minority ethnic (BAME) group mentioned increased stress and more cautious behaviour on receipt of the information of these being additional risk factors: 

Patients with SARDs do not appear to be at increased risk of contracting COVID-19 26 , while those who do become infected have been found to have a "small but significant" increased risk of death 26 , with other chronic conditions -including diabetes -having a far more substantial impact 27 . Consequently, the greater threat to many SARD patients might not have been COVID-19 itself but the NHS response in curtailing normal care 9 . In particular, the frequent cancellation of their appointments, problems accessing medications, and reduced monitoring of symptoms, may well have increased the risk of long term damage 28 , and possible death in severe cases 29 , from not quickly detecting 30 and treating flare-ups or responding to medication side-effects 10 .

Consistent with other studies 28 , we found that the adverse impact of diverting clinical care from SARD to COVID-19 patients was compounded by healthcare avoidance 31 by patients fearful of catching the virus and not wanting to be an additional burden on over-stretched clinicians. However, those who did attend hospital largely reported feeling safer than expected; and had a much quicker and improved experience compared to pre-pandemic visits due to reduced hospital activity. Inadequate knowledge of SARDs among physicians 11,,32,33,34 is likely to remain a major problem for these patients both in terms of feeling medically secure and obtaining the correct treatment, until greater focus is given to these diseases in medical training and research. One potential advantage of the pandemic is the increased medical focus on neuroinflammatory mechanisms 35 and pathological fatigue, experienced by many SARDs (and other patient groups such as MS and ME/CFS) patients, yet to date has been poorly understood and under-researched.

Our most concerning finding was that numerous, previously responsive, rheumatology departments and physicians were reported to not respond effectively (or at all in some cases) to repeated requests for medical advice and help. This was felt to have contributed not only to many patients deteriorating physically with some requiring hospitalisation, but also to a widespread sense of medical abandonment. Abandonment was also a major finding in a recent patient-view survey from the Rare Autoimmune Rheumatic Disease Alliance (RAIRDA) 36 . Conversely, our findings also indicated that physicians who contacted their patients and remained quickly accessible, positively influenced multiple patient-reported health outcomes. This included a strong positive correlation between patients feeling medically supported during the pandemic and how helpful their doctors were in answering COVID-19 risk questions (r=0.776). This is likely to reflect the more positive communication and care overall from physicians who took the time to give personalised risk information.

Unsolicited contact was particularly appreciated and viewed as demonstrating genuine care for the patient at a very anxious time for many. One UK rheumatology department reported that their continuation during the pandemic of an established helpline and clear, prompt communication of individual risks, whilst an 'enormous task', was felt to have provided continuity of care and reduced patient anxiety 9 .

Our previous research found that a trusting medical relationship, including reassurance of accessibility in a health crisis, is one of the key components of medical security 14 . Building trusting medical relationships is likely to have been adversely affected by the pandemic and may be further impacted by the widespread move to video/telephone consultations. Although some benefits of remote consultations were identified, especially in the short-term, we have serious concerns regarding the safety and acceptability of a long-term move post-pandemic to more remote consultations 37 for SARD patients. As we have shown previously, SARDs patients may carry a burden of medical insecurity and distrust of clinicians 11, 14 . Without face to face consultation, such patients may fail to re-establish the trust needed to discuss their concerns. Furthermore, many features of active SARDs are challenging to diagnose without physical examination and further tests 10 .

Highlighting these many negative impacts on care for SARD patients is essential for future planning, and does not diminish the great efforts and sacrifices made by many clinicians 38 .

COVID-19 has created an unprecedented, stressful and potentially life-threatening situation for clinicians and their patients. Both may have psychological distress and longer-term damage from their experiences, which need to be considered further.

Other studies 4 report that the COVID crisis prompted the cancellation of chronic care services and emphasise the importance of a continuing provision in order to prevent excess non-COVID mortality. Pope 39 The results may not be generalizable to the wider SLE and SARD population as participants were from a co-existing trial recruited to measure peer support, which may not have attracted a representative sample, and diagnoses were self-reported. However, study validity was strengthened through triangulating our quantitative and qualitative findings; anomalous case analysis 24 , and "member checking" 23 emerging themes with participants and LUPUS UK forum users, and the views expressed highlight multiple patient concerns that need managing in the future. As is commonly used in qualitative research, purposive 41 (purposeful selection to ensure a range of characteristics/opinions rather than random) sampling of interviewees from survey responses ensured a good range of socio-demographic and experience coverage.

A limitation is that we were unable to obtain many views from male patients. While they are in the minority with lupus (5-10% of cases), their views and experiences may differ. Ethnicity was more representative among interview participants due to purposive sampling, but sign-up to the study was proportionally lower in BAME groups, and this may have skewed the results. Bearing in mind that both SLE 10 and COVID 42 have a disproportionate impact on minority ethnic communities, there is a pressing need to prevent "widening disparities among patients with rheumatic diseases in the COVID-19 era" 43 .

In conclusion, it is essential that future pandemic planning facilitates appropriate, prompt care to all SARD patients with clear and accessible lines of communication. This will reduce the short and long-term costs (personal, NHS and societal) identified from inadequate routine and emergency care during the pandemic for this group of patients, many of whom have lifechanging and/or life-threatening disease. Future plans should consider the needs of particularly vulnerable subgroups.

NOTE: Impact of shielding/lockdown and Government policies will be presented in another paper.

This research idea was conceived from discussions and active input from multiple patients and rheumatologists. Patient representatives contributed fully throughout the research with an The most healthcare avoidant due to traumatic diagnostic journeys I have often waited and waited to go to the GP as it has taken a long long time to get diagnosed and spent years feeling like everyone thought I was a hypochondriac but I honestly knew something wasn't at all right and was steadily getting worse. (Ppt 134, 40s) 

NHS hospital bed numbers: past, present, future

Anatomising failure: there should be a statutory public inquiry into the UK Government's handling of COVID-19

Lessons for managing high-consequence infections from first COVID-19 cases in the UK. Correspondence

Health inequalities: the hidden cost of COVID-19 in NHS hospital trusts

The primary care response to COVID-19 in England's

Beyond the virus: ensuring continuity of care for people with diabetes during COVID-19

Virtual rheumatology during COVID-19: a personal perspective

On the alert for cytokine storm: immunopathology in COVID-19

Challenges in delivering rheumatology care during COVID-19 pandemic

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults

Medically explained symptoms: a mixed methods study of diagnostic, symptom and support experiences of patients with lupus and related systemic autoimmune diseases

Perspectives of medical specialists from different disciplines on the management of systemic lupus erythematosus: an interview study

Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view

Is it me? The impact of patient-physician interactions on lupus patients' psychological wellbeing, cognitions, and healthcare-seeking behaviour. Rheumatol Advan Pract 2020, rkaa037

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics

Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus

Estimation of the burden of shielding among a cross-section of patients attending rheumatology clinics with SLE. Data from the BSR audit of Systemic Lupus Erythematosus. Accepted pre-publication

Rapid risk assessment: coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK -eleventh update: resurgence of cases

Designing and conducting mixed methods research

The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation

Using thematic analysis in psychology

Member Checking: a tool to enhance trustworthiness or merely a nod to validation?

Integrating survey and ethnographic methods for systematic anomalous case analysis

Consolidated criteria for reporting qualitative research (COREQ): a 32 item checklist for interviews and focus groups

Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: a review

Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis

The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort

Survival of patients with SLE admitted to an intensive care unita retrospective study

Impact of COVID-19 pandemic on SLE: beyond the risk of infection

Reluctance to seek pediatric care during the COVID-19 pandemic and the risks of delayed diagnosis

Musculoskeletal medicine: an assessment of the attitudes and knowledge of medical students at Harvard medical school

Improved education in musculoskeletal conditions is necessary for all doctors

Referral and diagnosis of common rheumatic diseases by primary care physician

Changing dynamics of psychoneuroimmunology during the COVID-19 pandemic

Chronic crisis. The impact of COVID-19 on people with rare autoimmune rheumatic diseases. The Rare Autoimmune Rheumatic Disease Alliance

Teleneurology during the COVID-19 pandemic: A step forward in modernizing medical care

Sacrifice and risk in the time of COVID-19

What Does the COVID-19 Pandemic Mean for Rheumatology Patients? Curr Treatm Opt Rheumatol

The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care

Encyclopedia of survey research methods

Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities

Widening disparities among patients with rheumatic diseases in the COVID-19 era: an urgent call to action

Additional Supplementary information references

Ethics and politics in qualitative research

Three epistemological stances for qualitative inquiry: interpretivism, hermeneutics, and social constructionism

Theoretical Sensitivity: Advances in the Methodology of Grounded Theory